Project Partners: Department of Cell Biology, Rostock University Medical Center; Department of Microfluidics, University of Rostock
Funding: Ministry of Economics, Labor and Health Mecklenburg-Vorpommern together with the European Union (ERDF Project)
The grant from the Ministry of Economics, Infrastructure, Tourism and Labor of Mecklenburg-Vorpommern will enable the Medical Device manufacturer Human Med AG to significantly advance its work on important research and development projects. These include solutions for the surgical treatment of lipoedema, a fat distribution disorder that affects an estimated four million women in Germany alone.
Medical technology project with great innovation potential
The project serves to expand the innovative and application-oriented product portfolio of Human Med AG. Dr. Juliane Meyer, Head of Research & Development at Human Med AG, explains the significance of the project: “By interlinking industrial medical technology with the university research partners of the Department of Microfluidics at the University of Rostock and the Department of Cell Biology at Rostock University Medical Center, the latest state of technology and research is directly incorporated into the planned developments.” The project will run for three years, with a total volume of just under 2.4 million euros.
Research and development funding from the state of Mecklenburg-Vorpommern
The federal state of Mecklenburg-Vorpommern is providing support with the help of funds from the European Regional Development Fund (ERDF) as part of the “Directive on the granting of subsidies to promote research, development and innovation”. The aim of the grant is, on the one hand, to financially support Human Med AG as an innovative, research-based company. At the same time, the state of Mecklenburg-Vorpommern would like to strengthen the general innovation and competitiveness of the regional economy with grants of this kind.
